Switch to: References

Add citations

You must login to add citations.
  1. Vulnerability.Thiago Cunha & Volnei Garrafa - 2016 - Cambridge Quarterly of Healthcare Ethics 25 (2):197-208.
    Download  
     
    Export citation  
     
    Bookmark   2 citations  
  • “Who Am I to Judge These Things”: Intersectional Dimensions of Self-Silencing of People with a Neuromuscular Disease in a Clinical Trial.Floor Cuijpers, Maaike Muntinga, Minne Bakker, Gönül Dilaver, Mariëtte van den Hoven & Petra Verdonk - 2022 - International Journal of Feminist Approaches to Bioethics 15 (2):51-75.
    Ethical guidelines protecting medical research participants have been criticized for stripping the sociocultural contexts of research. This critique is urgent considering ongoing calls to account for participant diversity in recruitment and inclusion procedures. Our intersectional analysis of illness narratives explores how sociostructural factors might play a role in participants’ exposure to research-related harm in clinical trials. Although widening participation does respond to generalizability concerns, we argue that gendered, classed, and ableist processes of self-silencing could simultaneously enhance risk of harm for (...)
    Download  
     
    Export citation  
     
    Bookmark  
  • Ethical approval in developing countries is not optional.Edwin R. van Teijlingen & Padam P. Simkhada - 2012 - Journal of Medical Ethics 38 (7):428-430.
    When conducting health and medical research it is important to do the research ethically and to apply for prior ethical approval from the relevant authorities. The latter requirement is true for developed countries as well as developing countries. The authors argue that simply applying for research ethics approval from an institutional review board at a university based in a developed country is not enough to start a health research project in a developing country. The paper also suggests a number of (...)
    Download  
     
    Export citation  
     
    Bookmark   5 citations  
  • Enhancing capacity of ethics review committees in developing countries: The Kenyan example.Gloria Manyonyi, Walter Jaoko, Kirana Bhatt, Simon Langat, Gaudensia Mutua, Bashir Farah, Jacquelyne Nyange, Joyce Olenja, Julius Oyugi, Sabina Wakasiaka, Maureen Khaniri, Keith Fowke, Rupert Kaul & Omu Anzala - 2014 - South African Journal of Bioethics and Law 7 (2):59.
    Background. The increased number of clinical trials taking place in developing countries and the complexity of trial protocols mandate that local ethics review committees reviewing them have the capacity to ensure that they are conducted to the highest ethical standards.Methods. The Kenya AIDS Vaccine Initiative Institute of Clinical Research and the Kenyan National Council for Science and Technology embarked on an exercise to enhance the capacity of ERCs in Kenya to review such protocols. This process involved conducting an audit of (...)
    Download  
     
    Export citation  
     
    Bookmark   1 citation